Nanjing Yoko Biomedical Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Nanjing China (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2015
NCT02717741
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Nanjing Yoko Biomedical Co., Ltd.